Omastr Tablet (Limaprost Alpha-Dex)

Adult dosage

1. For improvement of ischemic symptoms such as ulcers, pain, and coldness due to thromboangiitis obliterans (Buerger's disease), the usual adult dose is 2 tablets orally 3 times daily. 2. For improvement of subjective symptoms (lower limb pain and numbness) and walking ability due to acquired lumbar spinal canal stenosis (patients with a normal SLR test and bilateral intermittent claudication), the usual adult dose is 1 tablet orally 3 times daily. Adjust the dose appropriately according to age and symptoms.

This medication should not be used by women who are pregnant or may become pregnant. Additionally, it contains lactose, therefore individuals with genetic issues such as galactose intolerance, Lapp lactase deficiency, and glucose-galactose malabsorption should not use this medication. Patients with bleeding tendencies or those taking antiplatelet agents, thrombolytics, or anticoagulants should use this medication with special caution. Use of this medication may cause allergic reactions such as skin rashes or itching, and if these symptoms occur, use should be discontinued immediately. Rarely, bleeding may occur, hence symptoms should be closely monitored and administration should be stopped if abnormalities are detected. Gastrointestinal effects may occur, leading to diarrhea, nausea, abdominal discomfort, abdominal pain, decreased appetite, heartburn, vomiting, and abdominal bloating. Liver function abnormalities may occur, necessitating attention to liver-related symptoms. Symptoms such as rapid heartbeat or cyanosis of hands and feet, low blood pressure may appear. Various side effects including headache, facial flushing, dizziness, heat sensation, generalized malaise, edema, mastitis, tremors, hirsutism, and anemia have also been reported. Patients with lumbar spinal stenosis should carefully observe their symptoms when deciding on the continued use of this medication. Particularly for severe cases requiring surgery, efficacy has not yet been established. Safety during pregnancy has not been established; hence, women who are pregnant or may become pregnant should not take this medication. Animal studies have reported uterine contraction effects; therefore, use during pregnancy may pose risks. Safety in pediatric patients has not been confirmed, so it is advisable not to use it in children. Elderly patients may have decreased body function, so caution should be exercised, including dose reduction.

• Rash
• pruritus
• bleeding
• diarrhea
• nausea
• abdominal discomfort
• abdominal pain
• loss of appetite
• heartburn
• vomiting

This medication must be stored in a tightly closed container to prevent contact with air or moisture, and should be kept at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the efficacy and safety of the medication.

Appearance

White round tablet

Package unit

84 tablets (21 tablets/PTP × 4)